- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
United Therapeutics Corp
+ Add to WatchlistUTHR:US
69.1700 USD 0.6900 1.01%As of 20:10:00 ET on 05/17/2013.
Company Profile for United Therapeutics Corp (UTHR)
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.
Contact Information
United Therapeutics Corp
1040 Spring Street
Silver Spring, MD 20910
United States
Key Executives for United Therapeutics Corp (UTHR)
| Martine A RothblattChairman/CEO/Founder | Roger A JeffsPresident/COO |
| John M FerrariCFO/Treasurer | Paul A MahonExec VP/Secy/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page